Collagen, type I, alpha 2
Collagen, type I, alpha 2 is a protein that in humans is encoded by the COL1A2 gene. It is a crucial component of type I collagen, which is the most abundant form of collagen in the human body. Type I collagen is a fibrillar collagen that provides structural support and strength to various tissues.
Structure[edit]
Type I collagen is a heterotrimeric protein composed of two alpha-1 chains and one alpha-2 chain. The alpha-2 chain is encoded by the COL1A2 gene located on chromosome 7q21.3. Each chain is characterized by a repeating Gly-X-Y sequence, where X and Y are frequently proline and hydroxyproline, respectively. This sequence allows the formation of a triple helix structure, which is stabilized by interchain hydrogen bonds.
Function[edit]
Collagen, type I, alpha 2, as part of type I collagen, plays a vital role in providing tensile strength and structural integrity to various tissues, including skin, tendon, ligament, bone, and cornea. It is essential for the normal development and maintenance of these tissues. The protein also plays a role in wound healing and tissue repair.
Biosynthesis[edit]
The biosynthesis of type I collagen involves several steps:
- Transcription: The COL1A2 gene is transcribed into mRNA in the cell nucleus.
- Translation: The mRNA is translated into the preprocollagen alpha-2 chain in the endoplasmic reticulum.
- Post-translational modifications: The preprocollagen undergoes hydroxylation of proline and lysine residues, glycosylation, and cleavage of signal peptides to form procollagen.
- Triple helix formation: Three procollagen chains assemble into a triple helix.
- Secretion and processing: The procollagen is secreted into the extracellular space, where it is cleaved by specific proteases to form mature collagen fibrils.
Clinical Significance[edit]
Mutations in the COL1A2 gene can lead to several disorders, most notably osteogenesis imperfecta, a condition characterized by brittle bones. Other conditions associated with COL1A2 mutations include Ehlers-Danlos syndrome and certain forms of osteoporosis.
Osteogenesis Imperfecta[edit]
Osteogenesis imperfecta (OI) is a genetic disorder that results in fragile bones. Mutations in the COL1A2 gene can disrupt the normal structure and function of type I collagen, leading to the clinical manifestations of OI, which include frequent fractures, bone deformities, and short stature.
Ehlers-Danlos Syndrome[edit]
Ehlers-Danlos syndrome (EDS) is a group of connective tissue disorders characterized by hypermobility, skin hyperextensibility, and tissue fragility. Mutations in COL1A2 can contribute to certain subtypes of EDS, affecting the integrity of collagen fibers.
Research and Therapeutic Approaches[edit]
Research into the COL1A2 gene and its protein product is ongoing, with a focus on understanding the molecular mechanisms underlying collagen-related disorders. Potential therapeutic approaches include gene therapy, the use of bisphosphonates to strengthen bone, and the development of small molecules to stabilize collagen structure.
See Also[edit]
External Links[edit]
- [GeneCards: COL1A2]
- [OMIM: COL1A2]
| Collagen | |
|---|---|
| File:Collagen.png | |
| Overview | |
| Type | Protein |
| Function | Structural component of connective tissues |
| Location | Skin, tendons, ligaments, cartilage, bone, blood vessels |
| Types | |
| Related Topics | |
| See Also | |
